Nova Ltd. (NVMI) came out with quarterly earnings of $2.33 per share, beating the Zacks Consensus Estimate of $2.2 per share. This compares to earnings of $2.18 per share a year ago.
Nova Eye Medical Limited (ELXMF) Q3 2026 Earnings Call Transcript
Purepoint Uranium Group Inc (TSX-V:PTU, OTCQX:PTUUF, FRA:P5X0) earlier this week reported strong drilling results from its Dorado joint venture project, highlighting significant progress at the Nova uranium discovery. The company's CEO, Chris Frostad, said the latest campaign had successfully extended mineralization to approximately one kilometre, confirming the scale and continuity of the system.
Purepoint Uranium Group Inc (TSX-V:PTU, OTCQX:PTUUF, FRA:P5X0) said on Tuesday its winter 2026 drill program at the Dorado joint venture project in northern Saskatchewan successfully extended uranium mineralization at the Nova discovery, supporting the potential scale of the find. The Vancouver-based explorer, which operates the project in a 50/50 partnership with IsoEnergy, completed nine drill holes totaling 5,210 metres within the Nova Zone in the Athabasca Basin, one of the world's richest uranium regions.
Bamco Inc. NY increased its stake in Nova Ltd. (NASDAQ: NVMI) by 1.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 109,692 shares of the semiconductor company's stock after purchasing an additional 1,987 shares during the quarter. Bamco Inc. NY
Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript
Nova Ltd. (NVMI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Nova Ltd. (NVMI) Q4 2025 Earnings Call Transcript
Nova Ltd. (NVMI) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $1.94 per share a year ago.
Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript
Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript
Nova Limited leads in integrated, in-line materials metrology, capitalizing on rising chip complexity and AI-driven demand. NVMI targets ~$1.15B revenue by 2027, implying a 14.4% CAGR, and demonstrates exceptional free cash flow conversion averaging 99.3% since 2021. I see a clear path to ~12.65% annual returns through 2030 if purchased at a 30x P/E multiple, with a conservative price target of $458.30.